Skip to main content

and
  1. Article

    Open Access

    Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

    The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug t...

    Liling Jiang, Yuening Sun, **xiang Wang in Journal of Experimental & Clinical Cancer … (2019)

  2. Article

    Open Access

    Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

    It has been well known that androgen receptor (AR) is critical to prostate cancer development and progression. It has also been documented that AR is expressed in more than 60% of breast tumors, which promotes...

    Yuning Liao, **aohong **a, Ningning Liu, Jianyu Cai, Zhiqiang Guo, Yanling Li in Oncogene (2018)

  3. No Access

    Article

    Preface

    Q. ** Dou in Cancer and Metastasis Reviews (2017)

  4. No Access

    Article

    Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing

    In the past 15 years, the proteasome has been validated as an anti-cancer drug target and 20S proteasome inhibitors (such as bortezomib and carfilzomib) have been approved by the FDA for the treatment of multi...

    Claire L. Soave, Tracey Guerin, **bao Liu, Q. ** Dou in Cancer and Metastasis Reviews (2017)

  5. Article

    Open Access

    Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents

    Deubiquitinases (DUBs) play an important role in protein quality control in eukaryotic cells due to their ability to specifically remove ubiquitin from substrate proteins. Therefore, recent findings have focus...

    **n Chen, Qianqian Yang, Lu **ao, Daolin Tang, Q. ** Dou in Cancer and Metastasis Reviews (2017)

  6. No Access

    Article

    A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

    Based on the central role of the ubiquitin–proteasome system (UPS) in the degradation of cellular proteins, proteasome inhibition has been considered an attractive approach for anticancer therapy. Deubiquitina...

    C Zhao, X Chen, D Zang, X Lan, S Liao, C Yang, P Zhang, J Wu, X Li, N Liu in Oncogene (2016)

  7. No Access

    Article

    Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells

    The purpose of present study is to examine the mechanism of the 5′-AMP-activated protein kinase (AMPK) activation induced by proteasome inhibitors. AMPK activation and ubiquitin proteasome system (UPS) inhibit...

    Rahul R. Deshmukh, Q. ** Dou in Breast Cancer Research and Treatment (2015)

  8. No Access

    Article

    Gene–environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men

    A single nucleotide polymorphism, rs10486567, in JAZF1 has consistently been associated with increased risk of prostate cancer. The physical interaction of zinc finger proteins, such as JAZF1, with heavy metals m...

    Christine Neslund-Dudas, Albert M. Levin in Cancer Causes & Control (2014)

  9. No Access

    Article

    Prostate Tissue Metal Levels and Prostate Cancer Recurrence in Smokers

    Although smoking is not associated with prostate cancer risk overall, smoking is associated with prostate cancer recurrence and mortality. Increased cadmium (Cd) exposure from smoking may play a role in progre...

    Christine Neslund-Dudas, Ashoka Kandegedara in Biological Trace Element Research (2014)

  10. No Access

    Article

    Association of Metals and Proteasome Activity in Erythrocytes of Prostate Cancer Patients and Controls

    Information is lacking on the effects toxic environmental metals may have on the 26S proteasome. The proteasome is a primary vehicle for selective degradation of damaged proteins in a cell and due to its role ...

    Christine Neslund-Dudas, Bharati Mitra in Biological Trace Element Research (2012)

  11. No Access

    Article

    Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor

    RNF115, or Breast Cancer-Associated Gene 2 (BCA2), encodes a RING-finger ubiquitin E3 ligase, expression of which was associated with estrogen receptor (ER)-positive status in human breast tumors. Although the...

    Fathima R. Kona, Karri Stark, Luke Bisoski in Breast Cancer Research and Treatment (2012)

  12. No Access

    Article

    Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines

    Thoracic malignancies and human breast cancer (HBC) continue to be aggressive solid tumors that are poor responders to the existing conventional standard chemotherapeutic approaches. Malignant pleural mesothel...

    Ying Wang, Arun K. Rishi in Cancer Chemotherapy and Pharmacology (2010)

  13. Article

    Open Access

    Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts

    Proteasome inhibition is an attractive approach to anticancer therapy and may have relevancy in breast cancer treatment. Natural products, such as dietary flavonoids, have been suggested as natural proteasome ...

    Di Chen, Kristin R Landis-Piwowar, Marina S Chen, Q ** Dou in Breast Cancer Research (2007)

  14. Article

    Open Access

    Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells

    A physiological feature of many tumor tissues and cells is the tendency to accumulate high concentrations of copper. While the precise role of copper in tumors is cryptic, copper, but not other trace metals, i...

    Kenyon G Daniel, Di Chen, Shirley Orlu, Qiuzhi Cindy Cui in Breast Cancer Research (2005)